Denali Therapeutics Inc. (DNLI) Social Stream
DENALI THERAPEUTICS INC (DNLI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering DNLI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 11 | $105 | $60 | $84.4 | $27.98 | 201.64% |
| 2021-11-17 | 11 | $105 | $60 | $84.3 | $27.98 | 201.29% |
| 2021-12-22 | 11 | $105 | $60 | $81.3 | $27.98 | 190.56% |
| 2022-01-13 | 11 | $105 | $60 | $80.5 | $27.98 | 187.71% |
| 2022-01-20 | 10 | $105 | $60 | $78.5 | $27.98 | 180.56% |
| 2022-02-10 | 10 | $105 | $60 | $76.1 | $27.98 | 171.98% |
| 2022-03-01 | 10 | $105 | $60 | $76.1 | $27.98 | 171.98% |
| 2022-05-06 | 11 | $105 | $41 | $73.2 | $27.98 | 161.62% |
| 2022-05-08 | 11 | $105 | $41 | $71.8 | $27.98 | 156.61% |
| 2022-05-13 | 11 | $105 | $41 | $70.3 | $27.98 | 151.25% |
| 2022-05-24 | 11 | $105 | $41 | $71.5 | $27.98 | 155.54% |
| 2022-08-16 | 12 | $105 | $39 | $67.909 | $27.98 | 142.71% |
The Trend in the Analyst Price Target
Over the past 19 months, DNLI's average price target has gone down $0.29.
Over the past 49 weeks, DNLI's average upside potential has been 124.52%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-06 | 11 | 105 | 60 | 80.500 | 43.96 | 83.12% |
| 2022-02-10 | 9 | 105 | 60 | 76.100 | 36.27 | 109.82% |
| 2022-05-08 | 11 | 105 | 41 | 71.800 | 23.05 | 211.5% |
| 2022-07-14 | 12 | 105 | 39 | 67.909 | 33.70 | 101.51% |
| 2022-08-10 | 12 | 105 | 39 | 67.909 | 38.53 | 76.25% |
DNLI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 9 | 1 | 2 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 52 weeks, DNLI's average broker recommendation rating improved by 0.66.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how DENALI THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1291.31% of that group.
- In the context of Pharmaceutical Products stocks, DENALI THERAPEUTICS INC's number of analysts covering the stock is higher than 1311.12% of them.
- In the context of Pharmaceutical Products stocks, DENALI THERAPEUTICS INC's average analyst price target is greater than 1307.58% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, DENALI THERAPEUTICS INC's variance in analysts' estimates is lower than -1127.83% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DENALI THERAPEUTICS INC are DNA, CRSP, and BNTX.
View All Top Stocks by Price Target
What is the outlook for DNLI? Use POWR Ratings for clearer insight into price direction.